Startups & Entrepreneurship
€9M Seed Turbo-Charges German ‘Nano-Uber’ That Delivers Cancer Drugs Door-to-Tumor
TL;DR * iDEL Therapeutics closes €9M seed round to advance tumor-targeted cancer therapies using synthetic shuttle technology * Choice, a SaaS platform for independent restaurants, closes $7.1M Series A to scale across Southern Europe * SBIR/STTR Programs Reauthorized by U.S. Congress with $4B Annual Funding for 4,000